![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19998-20010, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
, and
§¶
From the Using cDNA microarrays, we recently
identified a large number of transcripts that are regulated
differentially by the c-Myc oncoprotein in myeloid cells. Here, we
characterize one of these, termed MT-MC1 (Myc
Target in Myeloid Cells-1). MT-MC1
is a widely expressed nuclear protein whose overexpression, unlike that
of c-Myc targets reported previously, recapitulates multiple c-Myc phenotypes. These include promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation. The MT-MC1 promoter is a direct c-Myc
target; it contains two consensus E-box elements, both of which bind
c-Myc·Max heterodimers. Mutation of either site abrogates DNA binding
by c-Myc·Max and renders the promoter c-Myc unresponsive. Finally, MT-MC1 regulates the expression of several other c-Myc target
genes. MT-MC1 represents a proximal and direct c-Myc target that
recapitulates many of the properties typically associated with Myc
oncoprotein overexpression.
Section of Hematology/Oncology,
Children's Hospital of Pittsburgh, the § Department of
Molecular Genetics and Biochemistry, the University of
Pittsburgh, and the ¶ University of Pittsburgh Cancer
Institute, Pittsburgh, Pennsylvania 15213
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY09114.
To whom correspondence should be addressed: Section of
Hematology/Oncology, Children's Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, PA 15213. Tel.: 412-692-6797; Fax:
412-692-5723; E-mail: edward_prochownik@poplar.chp.edu.
This article has been cited by other articles:
![]() |
M. Niapour, Y. Yu, and S. A. Berger Regulation of Calpain Activity by c-Myc through Calpastatin and Promotion of Transformation in c-Myc-negative Cells by Calpastatin Suppression J. Biol. Chem., August 1, 2008; 283(31): 21371 - 21381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Rogulski, Q. Zhou, P. J. Sims, and E. V. Prochownik The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase I. Mol. Cell. Biol., May 1, 2006; 26(9): 3401 - 3413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik Deregulation of common genes by c-Myc and its direct target, MT-MC1 PNAS, December 27, 2005; 102(52): 18968 - 18973. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rothermund, K. Rogulski, E. Fernandes, A. Whiting, J. Sedivy, L. Pu, and E. V. Prochownik C-Myc-Independent Restoration of Multiple Phenotypes by Two C-Myc Target Genes with Overlapping Functions Cancer Res., March 15, 2005; 65(6): 2097 - 2107. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |